Peripheral ossifying fibroma mimicking oral Kaposi’s sarcoma in an immunosuppressed patient with Behçet’s disease: a case report Authors: Y. Sibari, A. Bouzidi, S. Chbicheb Published: 2026 ABSTRACT Introduction and importance:Kaposi’s sarcoma (KS) is an HHV-8-associated angioproliferative neoplasm occurring preferentially in immunosuppressed individuals, with oral involvement documented in up to 65% of HIV/AIDS patients. Several benign reactive gingival lesions, including peripheral ossifying fibroma (POF), may clinically mimic oral KS, creating a significant diagnostic challenge. In patients with established systemic KS, newly detected oral lesions carry a high risk of diagnostic anchoring bias, making HHV-8 (LANA-1) immunohistochemistry indispensable for definitive diagnosis.Presentation of case:A 57-year-old male with Behçet’s disease under long-term corticosteroid therapy (15 mg/day) and histologically confirmed cutaneous KS was referred for a painless gingival nodule evolving over 6 years. Intraoral examination revealed a well-demarcated, firm, pink, non-bleeding nodular lesion on the lingual mandibular gingiva, without bone involvement on panoramic radiography. The atypical clinical presentation prompted complete surgical excision under local anesthesia. Histopathology demonstrated a benign fibrocellular proliferation with focal mineralized deposits consistent with POF. HHV-8 LANA-1 immunohistochemistry, performed on the Autostainer Link 48 DAKO platform using the EnVision K5007 system, showed absent HHV-8 expression, definitively excluding oral KS. Healing was uneventful with no recurrence at 6 months.Clinical discussion:The coexistence of systemic KS and iatrogenic immunosuppression introduced a powerful cognitive prior – diagnostic anchoring bias – directing clinical reasoning toward mucosal KS despite four atypical features: pink coloration, firm consistency, absence of spontaneous bleeding, and 6-year indolent evolution. Negative HHV-8 immunostaining was decisive, confirming that oral lesions in KS patients are not necessarily mucosal disease. This case reinforces the principle that histopathological and immunohistochemical analysis must systematically override clinical gestalt in this setting.Conclusion:Early biopsy combined with HHV-8 (LANA-1) immunohistochemistry is essential when evaluating oral nodular lesions in immunosuppressed patients with established KS, to prevent diagnostic anchoring bias and avoid unnecessary oncologic investigations. Introduction Kaposi’s sarcoma (KS) is an HHV-8-associated vascular neoplasm occurring in classic, endemic, AIDS-related, and iatrogenic forms[1–3]. Oral involvement occurs in up to 65% of HIV/AIDS patients, with the hard palate (95%) and gingiva (23%) being the most frequently affected intraoral sites[2]; in 22% of cases, oral lesions are the initial site of manifestation[2,4]. Several benign reactive gingival lesions – pyogenic granuloma (PG), peripheral giant cell granuloma, and peripheral ossifying fibroma (POF) – may clinically mimic oral KS[2,5]. POF originates from periodontal ligament cells and is characterized by fibroblastic proliferation with mineralized components[6–8].HIGHLIGHTSPeripheral ossifying fibroma may clinically mimic oral Kaposi’s sarcoma (KS) in immunosuppressed patients.Oral nodular lesions in patients with systemic KS are not necessarily mucosal KS.HHV-8 (LANA-1) immunohistochemistry is essential for distinguishing KS from reactive gingival lesions.Early biopsy is critical to avoid misdiagnosis and unnecessary oncologic management. HIGHLIGHTS Peripheral ossifying fibroma may clinically mimic oral Kaposi’s sarcoma (KS) in immunosuppressed patients. Peripheral ossifying fibroma may clinically mimic oral Kaposi’s sarcoma (KS) in immunosuppressed patients. Oral nodular lesions in patients with systemic KS are not necessarily mucosal KS. Oral nodular lesions in patients with systemic KS are not necessarily mucosal KS. HHV-8 (LANA-1) immunohistochemistry is essential for distinguishing KS from reactive gingival lesions. HHV-8 (LANA-1) immunohistochemistry is essential for distinguishing KS from reactive gingival lesions. Early biopsy is critical to avoid misdiagnosis and unnecessary oncologic management. Early biopsy is critical to avoid misdiagnosis and unnecessary oncologic management. In patients with known systemic KS, newly detected oral lesions carry a high risk of diagnostic anchoring bias – a cognitive error whereby clinicians over-rely on a prior diagnosis and fail to revise their reasoning when contradictory evidence emerges – making HHV-8 (LANA-1) immunohistochemistry indispensable[9–11]. We report a rare case of POF mimicking oral KS in an immunosuppressed patient with Behçet’s disease and established cutaneous KS, in accordance with the SCARE 2025 guidelines[12]. Timeline The chronological sequence of events is summarized in Table 1. A delay of approximately 6 yr occurred between the patient-reported onset of the gingival lesion and referral, attributable to its painless, slowly evolving nature.Table 1Chronological timeline of clinical events Dates in dd/mm/yyyy format where known; estimated dates indicated.Date (dd/mm/yyyy)EventChildhood (unknown)Diagnosis of Behçet’s disease; initiation of follow-upUnknown (prior to 10/2022)Long-term corticosteroid therapy initiated (1 mg/kg/day, tapered to 15 mg/day) + colchicine 1 mg/day for occlusive retinal vasculitis10/2022Biopsy of violaceous nodules on both feet → cutaneous KS confirmed; HHV-8 (LANA-1) immunostaining positive~2018 (estimated)Onset of painless gingival nodule (lingual mandibular gingiva) – 6-year delay before consultation06/2024Referral to oral surgery; intraoral examination + panoramic radiography performed06/2024Surgical excision under local anesthesia (cold blade, en bloc to periosteum); specimen submitted for histopathology and HHV-8 IHC06/2024H&E: fibrocellular proliferation with mineralized deposits; HHV-8 LANA-1: negative → oral KS definitively excluded; POF confirmed1 week postoperativeFollow-up: uneventful healing, no complications1 month postoperativeFollow-up: progressive mucosal healing, no complications6 months postoperativeFinal follow-up: complete healing, normal gingival architecture, no recurrence (Clavien–Dindo grade 0) Table 1Chronological timeline of clinical events Dates in dd/mm/yyyy format where known; estimated dates indicated.Date (dd/mm/yyyy)EventChildhood (unknown)Diagnosis of Behçet’s disease; initiation of follow-upUnknown (prior to 10/2022)Long-term corticosteroid therapy initiated (1 mg/kg/day, tapered to 15 mg/day) + colchicine 1 mg/day for occlusive retinal vasculitis10/2022Biopsy of violaceous nodules on both feet → cutaneous KS confirmed; HHV-8 (LANA-1) immunostaining positive~2018 (estimated)Onset of painless gingival nodule (lingual mandibular gingiva) – 6-year delay before consultation06/2024Referral to oral surgery; intraoral examination + panoramic radiography performed06/2024Surgical excision under local anesthesia (cold blade, en bloc to periosteum); specimen submitted for histopathology and HHV-8 IHC06/2024H&E: fibrocellular proliferation with mineralized deposits; HHV-8 LANA-1: negative → oral KS definitively excluded; POF confirmed1 week postoperativeFollow-up: uneventful healing, no complications1 month postoperativeFollow-up: progressive mucosal healing, no complications6 months postoperativeFinal follow-up: complete healing, normal gingival architecture, no recurrence (Clavien–Dindo grade 0) Chronological timeline of clinical events Dates in dd/mm/yyyy format where known; estimated dates indicated. Case presentation Patient information A 57-year-old man was referred to the Department of Oral Surgery in June 2024 for a gingival lesion. He had been under follow-up for Behçet’s disease since childhood, with recurrent oral aphthous ulcers (more than three episodes per year), genital ulcer scars, and occlusive retinal vasculitis requiring intravenous corticosteroid boluses followed by long-term oral corticosteroid therapy (initial dose 1 mg/kg/day, tapered to 15 mg/day), combined with colchicine 1 mg/day and calcium/vitamin D supplementation. Kaposi sarcoma (KS) was diagnosed in October 2022 following biopsy of violaceous nodules on both feet; histopathology confirmed spindle-cell proliferation with positive immunostaining for HHV-8. Serology for HIV, hepatitis B, and hepatitis C was negative. He was a non-smoker and did not consume alcohol or use recreational drugs, and he had no relevant family history. Clinical findings Dermatological examination revealed violaceous angiomatous nodules on the feet and in the interdigital spaces, with lower-limb edema, and scattered violaceous macules on the hands and trunk, consistent with cutaneous KS. No cervical lymphadenopathy was detected. Intraoral examination revealed a well-demarcated, painless, firm, pink nodular lesion on the lingual aspect of the anterior mandibular gingiva (Fig. 1A) that was non-ulcerated and non-bleeding on manipulation and had been slowly evolving over 6 years. Dental plaque and calculus were present in the anterior mandibular region. Panoramic radiography showed no bone involvement (Fig. 1B). Figure 1.(A) Intraoral view showing a well-circumscribed, pink, nodular lesion on the lingual aspect of the anterior mandibular gingiva. (B) Panoramic radiograph showing no evidence of underlying bone involvement or osteolytic changes associated with the lesion. (A) Intraoral view showing a well-circumscribed, pink, nodular lesion on the lingual aspect of the anterior mandibular gingiva. (B) Panoramic radiograph showing no evidence of underlying bone involvement or osteolytic changes associated with the lesion. Diagnostic assessment and interpretations Given the coexistence of confirmed cutaneous KS and prolonged corticosteroid-induced immunosuppression, oral KS was the primary hypothesis. However, four features were atypical: (1) pink rather than violaceous coloration; (2) firm rather than compressible consistency, with no spontaneous bleeding; (3) indolent 6-year evolution inconsistent with the progressive course of oral KS; and (4) absence of bone involvement. The differential diagnoses considered were PG, peripheral giant cell granuloma (PGCG), benign salivary gland tumor, fibrous epulis, POF, and oral KS. Although PG, PGCG, and benign salivary gland tumor were considered less likely, the features remained insufficiently specific for a definitive diagnosis, making histopathological examination essential. Intervention Preoperative antibiotic prophylaxis (amoxicillin 2 g orally 1 hour prior) was administered, given the patient’s iatrogenic immunosuppression. Complete surgical excision was performed under local anesthesia (2% lidocaine with 1:100,000 epinephrine) using a cold-blade technique. The lesion was excised en bloc with healthy margins to the periosteum (Fig. 2A). Local irritants were addressed by ultrasonic scaling. Hemostasis was achieved by compression; no sutures were required. The specimen was fixed in 10% buffered formalin for histopathology. The procedure was performed by a resident under direct senior supervision in the outpatient oral surgery department of the Faculty of Dental Medicine in Rabat. Figure 2.(A) Immediate postoperative intraoral view showing the surgical site after complete excision of the lesion. (B) Gross appearance of the excised lesion, presenting as a well-circumscribed nodular mass consistent with a benign fibrous gingival lesion. (A) Immediate postoperative intraoral view showing the surgical site after complete excision of the lesion. (B) Gross appearance of the excised lesion, presenting as a well-circumscribed nodular mass consistent with a benign fibrous gingival lesion. Gross examination revealed a whitish tissue fragment measuring 1.5 × 1.0 × 0.6 cm (Fig. 2B). Hematoxylin and eosin staining demonstrated a benign fibrocellular proliferation of spindle-shaped fibroblasts within a collagenous stroma without cytological atypia and with focal mineralized deposits (bone trabeculae and cementum-like material) and a chronic inflammatory infiltrate. The overlying squamous epithelium was intact with elongated rete ridges (Fig. 3). Figure 3.Hematoxylin and eosin (H&E). (A) Fibrocellular connective tissue proliferation composed of spindle-shaped fibroblasts arranged within a collagenous stroma, without cytological atypia (×100). (B) Higher magnification shows spindle-shaped fibroblasts with focal mineralized deposits, consistent with peripheral ossifying fibroma (×400). Hematoxylin and eosin (H&E). (A) Fibrocellular connective tissue proliferation composed of spindle-shaped fibroblasts arranged within a collagenous stroma, without cytological atypia (×100). (B) Higher magnification shows spindle-shaped fibroblasts with focal mineralized deposits, consistent with peripheral ossifying fibroma (×400). Histology allowed systematic exclusion of differential diagnoses: absence of lobular capillary vascular proliferation excluded PG; absence of multinucleated giant cells excluded PGCG; mineralized deposits excluded a fibrous epulis; and absence of ductal or acinar structures excluded a benign salivary gland tumor. No KS features – spindle-cell fascicles, slit-like vascular spaces, or extravasated erythrocytes – were identified. HHV-8 LANA-1 immunohistochemistry, performed on deparaffinized sections using the DAKO EnVision K5007 system on the Autostainer Link 48 platform, demonstrated absence of HHV-8 expression, definitively excluding oral KS. The definitive diagnosis of POF was established on histopathological and immunohistochemical grounds. Follow-up and patient perspective Postoperative follow-up at 1 week, 1 month, and 6 months showed progressive mucosal healing without complications. At 6 months, the site showed complete healing with restoration of normal gingival architecture, no recurrence or adverse events, and no complications per the Clavien–Dindo classification. The patient reported complete satisfaction with management and outcome, and significant relief upon confirmation that the lesion was benign and unrelated to his known KS. He reported no functional discomfort, pain, or eating difficulties after healing and noted that the reassurance of the histopathological diagnosis positively affected his overall well-being. Discussion In HIV-negative patients on long-term corticosteroids, HHV-8 reactivation is driven by T-cell-mediated immunosuppression and dysregulation of viral oncoproteins. LANA, vFLIP, and vCyclin[3]. The rare association between Behçet’s disease and KS reflects both disease-related immune dysregulation and iatrogenic immunosuppression as independent facilitators of HHV-8-driven tumorigenesis[13,14]. Corticosteroid-induced KS in autoimmune conditions, while uncommon, is increasingly reported, reinforcing the need for vigilance when new lesions appear[14]. Oral KS manifests as pink to violaceous macules, plaques, or nodules, but these features are not pathognomonic. Among its mimickers, PG, PGCG, and POF share overlapping presentations. A retrospective analysis of 138 cases showed that bleeding tendency, color, consistency, and growth kinetics may orient the clinician, though histopathological confirmation remains mandatory[15]. PG is soft, highly vascular, and bleeds readily, reflecting its lobular capillary hemangioma histology[16]. PGCG characteristically shows a bluish-purple discoloration from its vascular component and extravasated erythrocytes, which may resemble the violaceous hue of KS[5]. POF presents as a firm, slow-growing, pink nodular mass from the interdental papilla, consistent with its fibro-osseous reactive nature[6–8]. Key distinguishing features between oral KS and POF are summarized in Table 2.Table 2Differential diagnosis between oral Kaposi’s sarcoma and peripheral ossifying fibroma.FeatureOral Kaposi’s sarcomaPeripheral ossifying fibromaEtiologyHHV-8 angioproliferative neoplasmReactive fibro-osseous lesionImmune statusAssociated withNo proven associationCommon sitesHard palate, gingivaInterdental papilla, anterior gingivaColorPink to violaceousPink or redConsistencySoft, compressible, friableFirm, fibrousGrowthProgressive, weeks to monthsSlow, longstandingBleedingFrequent, especially if ulceratedMild, on manipulationRadiologicalUsually none in early stagesUsually none; occasional calcificationsHistopathologySpindle cells, slit-like vascular spaces, HHV-8 (+)Fibrocellular proliferation, mineralized deposits, HHV-8 (-)HHV-8 LANA-1PositiveNegativeTreatmentOncologic evaluation; systemic chemotherapySurgical excision to periosteumRecurrenceDepends on disease control8–20% Table 2Differential diagnosis between oral Kaposi’s sarcoma and peripheral ossifying fibroma.FeatureOral Kaposi’s sarcomaPeripheral ossifying fibromaEtiologyHHV-8 angioproliferative neoplasmReactive fibro-osseous lesionImmune statusAssociated withNo proven associationCommon sitesHard palate, gingivaInterdental papilla, anterior gingivaColorPink to violaceousPink or redConsistencySoft, compressible, friableFirm, fibrousGrowthProgressive, weeks to monthsSlow, longstandingBleedingFrequent, especially if ulceratedMild, on manipulationRadiologicalUsually none in early stagesUsually none; occasional calcificationsHistopathologySpindle cells, slit-like vascular spaces, HHV-8 (+)Fibrocellular proliferation, mineralized deposits, HHV-8 (-)HHV-8 LANA-1PositiveNegativeTreatmentOncologic evaluation; systemic chemotherapySurgical excision to periosteumRecurrenceDepends on disease control8–20% Differential diagnosis between oral Kaposi’s sarcoma and peripheral ossifying fibroma. In this case, the established diagnosis of cutaneous KS created a powerful cognitive prior directing reasoning toward mucosal KS – a textbook illustration of diagnostic anchoring bias[9]. Four features were discordant with oral KS: pink coloration, firm consistency, absence of spontaneous bleeding, and a 6-year indolent evolution. Overriding this cognitive anchor was critical, as premature diagnostic closure may lead to unnecessary oncologic workup, empirical chemotherapy, or harmful modification of an established immunosuppressive regimen[9,17]. Histologically, POF shows fibrocellular proliferation with bone trabeculae, cementum-like deposits, and dystrophic calcifications arising from periodontal ligament cells[6,8]. Local irritants – dental plaque and calculus – are well-recognized contributors[6,18], providing an HHV-8-independent pathogenic explanation. KS, by contrast, shows spindle-cell fascicles forming slit-like vascular spaces with extravasated erythrocytes and hemosiderin, and is consistently HHV-8 positive[10,11]. HHV-8 LANA-1 immunohistochemistry is the diagnostic gold standard[10,11], and its negative result was decisive: it confirmed POF, established that the oral lesion was unrelated to systemic KS, and avoided unnecessary oncologic investigation[2,19]. Accurate diagnosis carries major management implications. Oral KS may require modification of the immunosuppressive regimen, intralesional chemotherapy, or systemic agents such as liposomal doxorubicin or paclitaxel[2,14]. In Behçet’s disease, any corticosteroid modification must be weighed against the risk of disease flare and ocular deterioration, making diagnostic precision particularly consequential. POF, by contrast, is managed by complete surgical excision to the periosteum with elimination of local irritants, as performed here. Reported recurrence rates of 8–20% necessitate long-term surveillance[18,20]; none was observed at 6 months. With expanding indications for immunosuppression across rheumatologic and inflammatory conditions, clinicians will increasingly encounter patients in whom HHV-8-related malignancies coexist with unrelated oral pathologies. Maintaining a broad differential and systematically applying histopathological and immunohistochemical analyses, rather than relying on clinical gestalt shaped by prior diagnoses, is essential to evidence-based care. Strengths include rigorous clinicopathological and immunohistochemical correlation, explicit discussion of anchoring bias as a preventable cognitive pitfall, and full SCARE 2025 compliance. Limitations include the single-case design precluding generalization, the 6-month follow-up being insufficient for long-term conclusions, and the absence of complementary molecular analysis, such as HHV-8 viral load quantification. Conclusion This case emphasizes the importance of a histology-driven diagnostic approach when evaluating oral lesions in immunosuppressed patients with Behçet’s disease and KS. Early biopsy, combined with HHV-8 immunohistochemistry, is essential to establish the correct diagnosis and prevent unnecessary oncologic investigations.